They'd better have the G4 ready for delivery to customers at the ASHP show otherwise they're going to have canceled contracts and no one will take them seriously anymore- not that they do now.
Like the other Valimeds, no one is going to buy these things, they'll be pay-per-use transactions except without the on going cuvette sales.
Still a highly niche market for compounded, high-risk, liquid meds.
Nothing much has changed except that they won't be selling cuvettes.
News 
Market Data 
Discover 
